History
  • No items yet
midpage
Equistar Chemicals, LP v. Clydeunion DB, Limited
579 S.W.3d 505
| Tex. App. | 2019
Read the full case

Background

  • Equistar bought two custom pumps from ClydeUnion; both exhibited subsynchronous vibrations and eventually sustained cracked shafts, making them unsafe to operate.
  • Equistar ran the pumps intermittently in late 2012–2013, engaged Bently Nevada for vibration data (showing excessive subsynchronous vibration), and later sent the pumps for evaluation and repair; Equistar then modified older pumps to meet capacity needs.
  • Equistar sued ClydeUnion for breach of warranty and related claims; ClydeUnion counterclaimed for breach of contract for nonpayment.
  • A jury found ClydeUnion breached an express warranty and awarded Equistar ~$391,694, but also found Equistar breached the contract and awarded ClydeUnion ~$150,781; the jury found Equistar gave notice but did not give a "reasonable opportunity to cure."
  • The trial court entered judgment for ClydeUnion (recovering its counterclaim) after applying the offer-of-settlement statute and awarding litigation-cost offsets; Equistar appealed.

Issues

Issue Plaintiff's Argument (Equistar) Defendant's Argument (ClydeUnion) Held
Admissibility of ClydeUnion experts' testimony (damages/time-to-repair) Townsend’s damages opinion was unreliable and conclusory because it rested on flawed assumptions (pumps should've been taken out in Mar 2013; repairs would take 10 weeks). Expert relied on Bently Nevada data and HydroTex bid and other experts; methodology was reliable and matched Equistar’s own damages methodology for the relevant months. Court overruled this issue; admitted testimony was within trial court’s discretion and not conclusory as to the decisive points.
Exclusion of ClydeUnion counsel’s October 2013 letter The letter was admissible and central to proving opportunity to cure and the time required for repairs; exclusion prejudiced Equistar. Letter was a settlement communication and inadmissible under Rules 403/408; much of its substance was cumulative. Court assumed error but found any exclusion harmless because the letter’s substance was cumulative of admitted testimony/evidence.
Jury finding that Equistar did not give a reasonable opportunity to cure That finding was immaterial and should have been disregarded because UCC and contract do not require a cure opportunity after acceptance; thus it cannot bar Equistar’s warranty recovery. The UCC and contract (Article 26) support an opportunity-to-cure requirement; jury finding is material to deny Equistar recovery. Court sustained Equistar’s challenge: no statutory or contractual right to cure after acceptance; the jury’s answer was immaterial and should have been disregarded.
Calculation/order of offsets under offer-of-settlement statute (litigation-cost offsets vs. counterclaim award) Litigation-cost offset must be applied after offsetting defendant’s counterclaim damages against plaintiff’s award, producing a mutual take-nothing judgment. Litigation costs are offset first against plaintiff’s damages; any remaining defendant counterclaim award stands as judgment for defendant. Court sustained Equistar’s challenge: statute requires computing the claimant’s recovery after netting counterclaim damages first, then offsetting litigation costs (resulting in judgment that both parties take nothing).

Key Cases Cited

  • Ford Motor Co. v. Ledesma, 242 S.W.3d 32 (Tex. 2007) (expert testimony admissibility requires reliable foundation)
  • Gharda USA, Inc. v. Control Sols., Inc., 464 S.W.3d 338 (Tex. 2015) (analytical gap doctrine for expert reliability)
  • Diamond Offshore Servs., Ltd. v. Williams, 542 S.W.3d 539 (Tex. 2018) (exclusion of noncumulative, qualitatively different evidence may be harmful)
  • City of San Antonio v. Pollock, 284 S.W.3d 809 (Tex. 2009) (conclusory expert testimony is legally insufficient)
  • Gappelberg v. Landrum, 666 S.W.2d 88 (Tex. 1984) (seller’s right to cure exists primarily where buyer rejects goods; no cure right after acceptance)
  • Bobo v. Varughese, 507 S.W.3d 817 (Tex. App.—Texarkana 2016) (interpretation of terms in settlement-offer context; discussed prejudgment interest and "award")
Read the full case

Case Details

Case Name: Equistar Chemicals, LP v. Clydeunion DB, Limited
Court Name: Court of Appeals of Texas
Date Published: May 16, 2019
Citation: 579 S.W.3d 505
Docket Number: 14-17-00791-CV
Court Abbreviation: Tex. App.